The $1.18M raised during the 2022 Climb to Cure campaign brings lender nearly halfway to $10M by 2025 goal ATLANTA–(BUSINESS WIRE)–Lendmark Financial Services, a leading provider of household credit and consumer loan solutions, has raised the bar for itself and launched a bold new campaign and goal: to raise $10 million total by 2025 to … [Read more…]
Transition to new brand now complete across 350 locations in 38 states LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) has announced the completion of its initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. With today’s announcement, CenterWell Home Health is now the official name for the more than … [Read more…]
Dr. Baxi will help shape the company’s scientific roadmap and support its vision of building technological solutions to improve patient outcomes CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that Shrujal Baxi, MD, MPH, has joined its leadership team as Chief Medical Officer. “Having a stellar scientific, medical, and regulatory … [Read more…]
LONDON–(BUSINESS WIRE)–#ElectricalServices–H.I.G. Capital, LLC (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that one of its affiliates has acquired CPS Building Services Limited (“CPS” or the “Company”), a leading UK provider of mechanical and electrical (M&E) services, from its founder. CPS’ current MD, … [Read more…]
Immusoft makes history with the first engineered B cell investigational therapy cleared for human trials Immusoft seeks to improve the treatment of MPS I, a rare childhood disease, through the use of its Immune System Programming (ISP™) approach that utilizes B cells as re-dosable biofactories for therapeutic protein delivery The company has received FDA Orphan … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that the Company will release its 2022 fiscal year end financial results after the close of the U.S. financial markets on September 8, 2022. The Company will host a conference call and live webcast with … [Read more…]
Camille Griffin Graham Correctional Institution, a state prison for women in Columbia, S.C., is the first in the nation to implement FDA-authorized PDTs in a correctional setting Collaboration delivers Pear’s reSET® and reSET-O®, for treatment of substance use disorder and opioid use disorder, for patients affected by addiction BOSTON & COLUMBIA, S.C.–(BUSINESS WIRE)–The S.C. Department … [Read more…]
DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that on August 30, 2022, the District Court of Harris County, Texas (the “Court”) made an oral ruling from the bench in open court at the conclusion of the … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that Christopher Kirk, PhD, Co-founder, President and Chief Scientific Officer, will participate in three upcoming investor conferences in September. Presentation Details: Event: 2022 Wells Fargo Healthcare Conference Location: Boston, … [Read more…]
CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that CEO Matthias Schroff will provide a live presentation at the 2022 Chardan Genetic Medicines Conference, occurring October 3-4, 2022. … [Read more…]
